Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

1.

Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections.

Phee LM, Betts JW, Bharathan B, Wareham DW.

Antimicrob Agents Chemother. 2015 Aug;59(8):4544-50. doi: 10.1128/AAC.00753-15. Epub 2015 May 18.

PMID:
25987639
2.

Comparative virulence of urinary and bloodstream isolates of extra-intestinal pathogenic Escherichia coli in a Galleria mellonella model.

Ciesielczuk H, Betts J, Phee L, Doumith M, Hope R, Woodford N, Wareham DW.

Virulence. 2015;6(2):145-51. doi: 10.4161/21505594.2014.988095.

PMID:
25853733
3.

Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability.

Makena A, Brem J, Pfeffer I, Geffen RE, Wilkins SE, Tarhonskaya H, Flashman E, Phee LM, Wareham DW, Schofield CJ.

J Antimicrob Chemother. 2015 Feb;70(2):463-9. doi: 10.1093/jac/dku403. Epub 2014 Oct 16.

4.

Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin.

Personne Y, Curtis MA, Wareham DW, Waite RD.

J Antimicrob Chemother. 2014 Dec;69(12):3236-43. doi: 10.1093/jac/dku309. Epub 2014 Aug 18.

PMID:
25134721
5.
6.

Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia.

Betts JW, Phee LM, Woodford N, Wareham DW.

Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1565-72. doi: 10.1007/s10096-014-2101-3. Epub 2014 Apr 30.

PMID:
24781003
7.

In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae.

Betts JW, Phee LM, Hornsey M, Woodford N, Wareham DW.

Antimicrob Agents Chemother. 2014 Jun;58(6):3541-6. doi: 10.1128/AAC.02449-14. Epub 2014 Mar 31.

8.

Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making?

Woodford N, Wareham DW, Guerra B, Teale C.

J Antimicrob Chemother. 2014 Feb;69(2):287-91. doi: 10.1093/jac/dkt392. Epub 2013 Oct 3. Review.

9.

Development and evaluation of a multiplex PCR for eight plasmid-mediated quinolone-resistance determinants.

Ciesielczuk H, Hornsey M, Choi V, Woodford N, Wareham DW.

J Med Microbiol. 2013 Dec;62(Pt 12):1823-7. doi: 10.1099/jmm.0.064428-0. Epub 2013 Sep 2.

PMID:
24000223
10.

In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens.

Hornsey M, Phee L, Stubbings W, Wareham DW.

Int J Antimicrob Agents. 2013 Oct;42(4):343-6. doi: 10.1016/j.ijantimicag.2013.05.010. Epub 2013 Jul 7.

PMID:
23837926
11.

Antifungal synergy of theaflavin and epicatechin combinations against Candida albicans.

Betts JW, Wareham DW, Haswell SJ, Kelly SM.

J Microbiol Biotechnol. 2013 Sep 28;23(9):1322-6.

12.

In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens.

Phee L, Hornsey M, Wareham DW.

Eur J Clin Microbiol Infect Dis. 2013 Oct;32(10):1291-4. doi: 10.1007/s10096-013-1875-z. Epub 2013 Apr 23.

PMID:
23609511
13.

In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.

Hornsey M, Phee L, Longshaw C, Wareham DW.

Int J Antimicrob Agents. 2013 Mar;41(3):285-7. doi: 10.1016/j.ijantimicag.2012.11.013. Epub 2013 Jan 9.

PMID:
23312607
14.

Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase.

Hornsey M, Phee L, Woodford N, Turton J, Meunier D, Thomas C, Wareham DW.

J Clin Pathol. 2013 Apr;66(4):348-50. doi: 10.1136/jclinpath-2012-201234. Epub 2013 Jan 2.

PMID:
23288920
15.

Association of extended-spectrum β-lactamase VEB-5 and 16S rRNA methyltransferase armA in Salmonella enterica from the United Kingdom.

Hidalgo L, Hopkins KL, Wareham DW, Gutierrez B, González-Zorn B.

Antimicrob Agents Chemother. 2012 Sep;56(9):4985-7. doi: 10.1128/AAC.00381-12. Epub 2012 Jun 18. No abstract available.

16.

In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens.

Hornsey M, Longshaw C, Phee L, Wareham DW.

Antimicrob Agents Chemother. 2012 Jun;56(6):3080-5. doi: 10.1128/AAC.05870-11. Epub 2012 Apr 9.

17.

A simple, semiselective medium for anaerobic isolation of anginosus group streptococci from patients with chronic lung disease.

Waite RD, Wareham DW, Gardiner S, Whiley RA.

J Clin Microbiol. 2012 Apr;50(4):1430-2. doi: 10.1128/JCM.06184-11. Epub 2012 Jan 11.

18.

A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom.

Hornsey M, Phee L, Wareham DW.

Antimicrob Agents Chemother. 2011 Dec;55(12):5952-4. doi: 10.1128/AAC.05108-11. Epub 2011 Sep 19.

19.

Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy.

Hornsey M, Loman N, Wareham DW, Ellington MJ, Pallen MJ, Turton JF, Underwood A, Gaulton T, Thomas CP, Doumith M, Livermore DM, Woodford N.

J Antimicrob Chemother. 2011 Jul;66(7):1499-503. doi: 10.1093/jac/dkr168. Epub 2011 May 12.

20.

In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection.

Hornsey M, Wareham DW.

Antimicrob Agents Chemother. 2011 Jul;55(7):3534-7. doi: 10.1128/AAC.00230-11. Epub 2011 Apr 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk